ABSTRACT
Influenza is a highly contagious disease due to its frequently mutating viral Hemaglutinin (HA) and Neuraminidase (NA) proteins.[1] WHO reports that 250,000-500,000 people worldwide die of seasonal influenza every year.[2]This necessitates the search for universal vaccines, or broadly protective influenza vaccines. This research explored the feasibility of epitope-based broad-spectrum influenza H3 vaccine design based on common linear epitopes. Given the previously prepared broadly neutralizing antibody 4E3 that recognizes multiple H3 strains by NIDVD, three epitope candidates were selected using computer-simulated antigen-antibody docking. The three epitopes were then evaluated in vitro using molecular cloning, protein expression and immunoassay technologies. EPI-3 (amino acid sequence: WGVHHPVTDNDQIFLYAQA) was successfully cloned, expressed, and evaluated using Western Blot. The positive WB result proved the methodological validity of epitope-based broad-spectrum vaccine design using computational biology. Further work using this method is expected from the scientific community.
- Tamar Ben-Yedidia and Ruth Arnon, Epitope-based vaccine against influenza, Expert Rev. Vaccines 6(6), 939--938 (2007).Google ScholarCross Ref
- WHO 56th World Health Assembly 17 March 2003, Influenza Report www.who.int/gb/ebwha/phf_files/wha56/ea5623.pdf.Google Scholar
- Manzoli, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr. Infect. Dis. J.26(2), 97--106 (2007).Google ScholarCross Ref
- Jefferson T, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev. CD001269 (2007)Google Scholar
- RinoRappuoli, The challenge of developing universal vaccines, F1000 Medicine Reports 2011, 3:16.Google Scholar
- Qingbing Zhen, Action Mechanism of Broad-spectrum Monoclonal Antibodies against Haemagglutinin of Influenza A Viruses and Application of HA MAbs in the Treatment of Influenza. Doctoral Thesis. Xiamen University.Google Scholar
- Anthony W. Purcell, James McCluskey and Jamie Rossjohn, More than one reason to rethink the use of peptides in vaccine design, Nature, May 2007, Volume 6.Google Scholar
- Taia T. Wang, Gene S. Tan, Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes, PNAS, Nov. 2, 2010, vol. 107, no. 44.Google Scholar
- Anette Schneemann, Jeffrey A. Speir, A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin, J. Virol., Nov. 2012, volume 86, no. 21.Google Scholar
- Jong-Soo Lee, Mohammed Y.E. Chowdhury, The highly conserved HA2 protein of the influenza a virus induces a cross protective immune response, J. Virological Methods 194 (2013) 280--288.Google ScholarCross Ref
- Ref. DassaultSystèmes BIOVIA, Discovery Studio Modeling Environment, Release 2017, San Diego: DassaultSystèmes, 2016.Google Scholar
Index Terms
- An Exploration of Epitope-Based Vaccine Design with Broad Protection Against Influenza A (H3) Viral Strains Using Computational Biology
Recommendations
A novel in silico minigene vaccine based on CD4+ T-helper and B-cell epitopes of EG95 isolates for vaccination against cystic echinococcosis
Display Omitted An in silico multiepitope sheep-specific vaccine was designed based on ovar MHC class II alleles.Comprehensive computational methodologies was applied for the construction of minigene vaccine against E. granulosus.In silico epitope ...
Screening of immune epitope in the proteome of the Dabie bandavirus, SFTS, to design a protein-specific and proteome-wide vaccine for immune response instigation using an immunoinformatics approaches
AbstractTick-borne viruses are a major risk from tick bites, which could result in viral infectious diseases among animals and humans. Bunyavirus causes severe fever with thrombocytopenia syndrome (SFTS), with signs and symptoms including high ...
Highlights- Tick-borne viruses are a major risk from tick bites, which result in viral infectious diseases among animals and humans.
In silico designing breast cancer peptide vaccine for binding to MHC class I and II
Display Omitted Novel method of evaluating the affinity of candidate peptides to MHCs is proposed.The peptide 1412 identified as the best MHC binder to the most of applied MHCs.These findings can be exploited in vaccine design and cancer therapy. ...
Comments